Acute Myeloid Leukemia

The Food and Drug Administration granted a Fast Track Designation to CPX-351 for the treatment of elderly patients with relapsed acute myeloid leukemia (AML).

In a first-in-human study, the drug AG-221 generated long-lasting remissions in patients with acute myeloid leukemia (AML).

Updates from the annual meeting of the American Society of Hematology.

Liposomal anthracycline may allow for higher dosing with less cardiotoxicity in childhood AML patients.

The latest in cancer prevention, diagnosis & treatment.

When considering a stem cell transplantation, patients with cancer must be willing to take a chance.

Minimizing and preventing late effects of stem cell transplantation.

A drug removed from the market last year to treat acute myeloid leukemia may have a second life.

Research updates from the annual San Antonio Breast Cancer Symposium and American Society of Hematology.

Adolescents with AML tend to do better with stem cell transplant.

Treatment differs for Acute myeloid leukemia pediatric patients compared with older adults.

Updates from the annual meetings of the American Society of Hematology and the San Antonio Breast Cancer Symposium.

The latest in cancer prevention, diagnosis & treatment.

Leukemia is more than just one disease.

Advances in stem cell transplantation leads to a changing landscape in treating blood cancers, such as lymphoma, leukemia, and multiple myeloma.

The Leukemia and Lymphoma Society's "First Connection" program connects volunteers with newly diagnosed patients and caregivers to help them manage the many aspects of a cancer diagnosis.

Flipping cancer's "off" switch.

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.

Discussion of new drugs for CLL and to relieve constipation.

Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.

CML survivor Erin Zammett Ruddy wants a baby. The trade-off may be her health.

Drugs for multiple myeloma and CML reach patients.

Survivors guided through territory of long-term and late effects.

Cancer survivors deal with fear.

In addition to treatment-related risks, some survivors discover they have a genetic syndrome that may lead to a second cancer.

Updates from the 2006 annual meeting of the American Society of Clinical Oncology.